6:01 AM ET
8-K
Shareholder Meeting
Sonoma Pharmaceuticals Shareholder Meeting
Sonoma Pharmaceuticals held its annual meeting of stockholders on September 16, 2026, where shareholders elected Jerry McLaughlin as a Class III director. Stockholders also approved executive compensation on an advisory basis and ratified the appointment of Frazier & Deeter, LLC as the company's independent accounting firm for the fiscal year ending March 31, 2027.